HK Stock MarketDetailed Quotes
00954 CHANGMAO BIO
- 0.450
- 0.0000.00%
Market Closed Oct 4 16:08 CST
238.37MMarket Cap-2000P/E (TTM)
0.000High0.000Low0Volume0.450Open0.450Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)529.70MShares0.61052wk High0.34P/B82.67MFloat Cap0.35052wk Low--Dividend TTM183.70MShs Float5.039Historical High--Dividend LFY0.00%Amplitude-0.119Historical Low--Avg Price4000Lot Size--Div YieldTTM--Div Yield LFY
CHANGMAO BIO Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.80%313.8M | -12.73%637.08M | -22.52%296.61M | 33.22%730.03M | 55.39%382.81M | 23.39%547.98M | 12.01%246.36M | -10.21%444.11M | -26.17%219.95M | -22.62%494.58M |
| Operating income | 5.80%313.8M | -12.73%637.08M | -22.52%296.61M | 33.22%730.03M | 55.39%382.81M | 23.39%547.98M | 12.01%246.36M | -10.21%444.11M | -26.17%219.95M | -22.62%494.58M |
| Cost of sales | -16.73%-297.82M | -11.30%-611.27M | 12.56%-255.14M | -7.84%-549.2M | -34.72%-291.8M | -46.07%-509.3M | -27.43%-216.6M | 3.00%-348.66M | 16.28%-169.98M | 29.44%-359.43M |
| Operating expenses | -16.73%-297.82M | -11.30%-611.27M | 12.56%-255.14M | -7.84%-549.2M | -34.72%-291.8M | -46.07%-509.3M | -27.43%-216.6M | 3.00%-348.66M | 16.28%-169.98M | 29.44%-359.43M |
| Gross profit | -61.45%15.99M | -85.73%25.81M | -54.44%41.47M | 367.51%180.83M | 205.88%91.02M | -59.48%38.68M | -40.46%29.76M | -29.38%95.45M | -47.32%49.97M | 4.18%135.16M |
| Selling expenses | -16.69%-4.19M | -3.18%-8.69M | -11.55%-3.59M | -2.57%-8.42M | 5.98%-3.22M | -29.50%-8.21M | 44.48%-3.43M | 54.92%-6.34M | 16.25%-6.17M | 7.28%-14.06M |
| Administrative expenses | -5.25%-33.72M | 15.73%-74.62M | 22.35%-32.03M | -20.49%-88.55M | -40.83%-41.26M | -3.66%-73.49M | -18.65%-29.3M | -16.28%-70.89M | 39.26%-24.69M | 4.08%-60.96M |
| Impairment and provision | ---- | -234.56%-183K | ---- | 585.71%136K | -98.91%2K | -123.33%-28K | 88.66%183K | -65.12%120K | -54.88%97K | 126.38%344K |
| -Other impairment is provision | ---- | -234.56%-183K | ---- | 585.71%136K | -98.91%2K | -123.33%-28K | 88.66%183K | -65.12%120K | -54.88%97K | 126.38%344K |
| Special items of operating profit | 155.86%7.35M | 4.86%5.63M | 7.28%2.87M | -95.83%5.37M | 41.17%2.68M | 9,702.68%128.87M | 54.98%1.9M | -157.45%-1.34M | -40.70%1.22M | -59.41%2.34M |
| Operating profit | -267.21%-14.57M | -158.24%-52.05M | -82.29%8.72M | 4.14%89.37M | 5,642.34%49.22M | 404.88%85.82M | -104.35%-888K | -72.94%17M | -58.41%20.43M | 13.27%62.81M |
| Financing income | 8.30%535K | 11.81%1.05M | -3.52%494K | 75.05%940K | 63.06%512K | 149.77%537K | 220.41%314K | -18.56%215K | 128.99%98K | -10.81%264K |
| Financing cost | -6.04%-3.41M | -184.11%-7.58M | -103.74%-3.21M | -36.73%-2.67M | -180.43%-1.58M | -3,048.39%-1.95M | -1,378.95%-562K | 88.10%-62K | ---38K | 54.66%-521K |
| Earning before tax | -390.80%-17.44M | -166.84%-58.58M | -87.54%6M | 3.83%87.64M | 4,338.73%48.15M | 392.12%84.41M | -105.54%-1.14M | -72.58%17.15M | -58.00%20.49M | 14.56%62.55M |
| Tax | 45.53%-1.13M | -344.45%-27.94M | 72.23%-2.08M | 76.01%-6.29M | -748.06%-7.5M | -6,306.36%-26.2M | 120.99%1.16M | 91.16%-409K | 14.91%-5.51M | 1.41%-4.63M |
| After-tax profit from continuing operations | -574.36%-18.58M | -206.34%-86.52M | -90.37%3.92M | 39.77%81.36M | 193,490.48%40.65M | 247.65%58.21M | -99.86%21K | -71.10%16.74M | -64.59%14.98M | 16.07%57.93M |
| Earning after tax | -574.36%-18.58M | -206.34%-86.52M | -90.37%3.92M | 39.77%81.36M | 193,490.48%40.65M | 247.65%58.21M | -99.86%21K | -71.10%16.74M | -64.59%14.98M | 16.07%57.93M |
| Minority profit | 187.14%210K | -609.23%-461K | -6.64%-241K | 41.44%-65K | -2.26%-226K | -32.14%-111K | -9.41%-221K | 77.42%-84K | 11.79%-202K | 39.61%-372K |
| Profit attributable to shareholders | -551.91%-18.79M | -205.69%-86.06M | -89.83%4.16M | 39.62%81.42M | 16,792.56%40.88M | 246.57%58.32M | -98.41%242K | -71.14%16.83M | -64.31%15.18M | 15.39%58.3M |
| Basic earnings per share | -537.50%-0.035 | -205.19%-0.162 | -89.61%0.008 | 40.00%0.154 | 0.077 | 243.75%0.11 | 0 | -70.91%0.032 | -63.75%0.029 | 15.79%0.11 |
| Diluted earnings per share | -537.50%-0.035 | -205.19%-0.162 | -89.61%0.008 | 40.00%0.154 | 0.077 | 243.75%0.11 | 0 | -70.91%0.032 | -63.75%0.029 | 15.79%0.11 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data